Status:

COMPLETED

Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

University of Texas

Conditions:

Cocaine Abuse

Cocaine-Related Disorders

Eligibility:

All Genders

18-55 years

Phase:

PHASE2

Brief Summary

Cocaine dependence is a major public health problem; an effective primary treatment for cocaine dependent individuals has yet to be found. The purpose of this study is to examine the effectiveness of ...

Detailed Description

Cocaine is a strong central nervous system stimulant that is widely abused throughout the United States. Due to its widespread use, it is important to develop an effective treatment for cocaine depend...

Eligibility Criteria

Inclusion

  • Meets DSM-IV criteria for current cocaine dependence
  • Provides at least one positive urine test for cocaine during study screening
  • Good general health, based on a physical exam, lab tests, and an electrocardiogram
  • Reads and writes English at a sixth grade level

Exclusion

  • Current Axis I depressive, psychotic, or anxiety disorder
  • Currently in jail
  • Pregnant or breastfeeding
  • Requires certain medications

Key Trial Info

Start Date :

March 1 2000

Trial Type :

INTERVENTIONAL

End Date :

October 1 2007

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT00218075

Start Date

March 1 2000

End Date

October 1 2007

Last Update

January 5 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Texas Health Science Center

Houston, Texas, United States, 77030